Cardiologist: GLP-1 Drugs Benefits Beyond Weight Loss for Heart, Liver

Cardiologist Dmitry Yaranov states GLP-1 drugs like Ozempic, Wegovy, and Mounjaro offer benefits far beyond weight loss. They enhance cardiovascular health, combat fatty liver disease, and improve blood sugar control in diabetes patients. These medications could redefine treatment for heart, liver, and metabolic diseases.

Cardiologist on the Expanding Role of GLP-1 Medications

Dmitry Yaranov, a cardiologist specializing in advanced heart failure, heart transplants, and mechanical circulatory support, shares insights on GLP-1 medications such as Ozempic, Wegovy, and Mounjaro.

These drugs provide benefits that extend well beyond weight loss, positioning them as potential game-changers in managing chronic conditions.

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store

Get it onGoogle Play

Key Benefits for Heart, Liver, and Metabolic Health

Improved cardiovascular health: GLP-1 drugs support better heart function and reduce related risks.
Reduction in fatty liver disease: They help address non-alcoholic fatty liver issues common in metabolic disorders.
Enhanced blood sugar control: Ideal for diabetes management, promoting stable glucose levels.

Yaranov emphasizes that GLP-1 medications represent the future of treating heart, liver, and metabolic diseases through multifaceted mechanisms.

Source Information

Originally published by Hindustan Times.Read the original article →

Keep exploring

More on Ozempic

Articles covering Ozempic dosing, side effects, and clinical updates.

Health & Wellness

What's the Deal with Peptides? The Hyped Market Under FDA Review

An in-depth look at the FDA's review of unregulated peptide therapy, the safety concerns raised by experts, and the conflict between industry demand and clinical evidence.

8 min read

Health & Wellness

Eli Lilly, Novo Nordisk Address Awareness Gap for Medicare’s $50 GLP-1 Program

Learn how the new Medicare GLP-1 Bridge program works, which drugs are covered, and why major pharmaceutical companies are leading the awareness push for the $50 copay initiative.

8 min read

Medical Research

Eli Lilly's Retatrutide Shows Cardiovascular and Diabetic Benefits in Trials

Eli Lilly's investigational drug, retatrutide, has shown promising results in clinical trials, offering substantial weight loss and significant improvements in cardiovascular health and type 2 diabetes management.

7 min read

Same topic: GLP-1

All GLP-1 articles →

Pharmaceutical Industry News

Samsung Biologics Acquires PolyPeptide for $1.8 Billion to Expand Peptide Therapeutics

Samsung Biologics has announced a major acquisition of PolyPeptide Group AG for $1.8 billion, marking a strategic expansion into the rapidly growing peptide therapeutics market, particularly for GLP-1 drugs.

8 min read

More in GLP-1 Medications

GLP-1 Medications

South Africa's 2026 Agenda Spotlights GLP-1 Obesity Drugs

One-third of South Africans live with obesity, driving new clinical guidelines that endorse GLP-1 drugs like Ozempic, Mounjaro, and Wegovy. These medications lower blood sugar, slow digestion, and promote fullness but face affordability barriers. Experts urge political action for broader access.

4 min read

GLP-1 Medications

Seoul Hoards 66% of GLP-1 Supply as High-Risk Areas Lack

Two-thirds of South Korea's GLP-1 obesity drugs, including Wegovy and Mounjaro, flow to Greater Seoul despite higher obesity rates elsewhere. This supply imbalance raises alarms over access for high-risk patients. Data reveals stark regional disparities in distribution.

2 min read

GLP-1 Medications

3 Arrested for $16K GLP-1 Drug Robbery at Pharmacy

Three suspects face robbery charges after stealing $16,000 worth of GLP-1 weight loss drugs, including Ozempic, Mounjaro, and Trulicity, from a pharmacy delivery in Bensalem, Pennsylvania. Police quickly apprehended the men from New York following a high-speed chase. The incident highlights surging demand for these popular medications.

1 min read